Business

Gilead Sciences recently announced the success of its experimental twice-yearly medicine, lenacapavir, in preventing HIV in a late-stage trial. The results of the trial showed that all 2,000 women who received the shot remained HIV-free, prompting optimism in the fight against the virus. This breakthrough could revolutionize the landscape of HIV prevention and treatment, providing
0 Comments
Fisker, a well-known all-electric vehicle startup, recently made headlines by filing for Chapter 11 bankruptcy protection. This move was primarily driven by lackluster consumer demand, significant cash burn, and operational and product issues. The company’s charismatic founder and CEO, Henrik Fisker, had previously expressed concerns about its ability to continue as a viable business, leading
0 Comments